EICHOR
● Recruiting
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
Condition: Non-Muscle Invasive Bladder Cancer · Sponsor: Memorial Sloan Kettering Cancer Center
About this study
The purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be compared to usual care with other NCCN-recommended standard treatments for NMIBC (gemcitabine with or without docetaxel, mitomycin, re-treatment with BCG, or pembrolizumab).
This description comes directly from the study's public registry record.
Talk to the study team
Eugene Pietzak, MD · 646-422-4781 · pietzake@mskcc.org
Bernard Bochner, MD · 646-422-4387
Always discuss trial participation with your own doctor first.
Locations (9)
| Johns Hopkins University (Data Collection Only) | Baltimore, Maryland, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Basking Ridge (Consent Only) | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth (Consent Only) | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen (Consent Only) | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Suffolk - Commack (Consent Only) | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester (Consent Only) | East White Plains, New York, United States | Recruiting |
| Columbia University (Data Collection Only) | New York, New York, United States | Not Yet Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau (Consent Only) | Uniondale, New York, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06929286